Locally Advanced Malignant Solid Neoplasm Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
- Locally Advanced Cholangiocarcinoma
- +28 more
- Avelumab
- +2 more
- Sacramento, California
- +6 more
2022-03-30
Mar 30, 2022M
Recruiting
- Locally Advanced Malignant Solid Neoplasm
- Pembrolizumab
- Houston, TexasM D Anderson Cancer Center
2022-03-22
Mar 22, 2022N
Active, not recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +8 more
- Dabrafenib Mesylate
- +2 more
- Los Angeles, California
- +15 more
2022-03-25
Mar 25, 2022N
Recruiting
- Locally Advanced Malignant Solid Neoplasm
- +2 more
- Capecitabine
- +6 more
- Bethesda, MarylandNational Cancer Institute Developmental Therapeutics Clinic
2022-03-17
Mar 17, 2022F
Suspended
- Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
- +33 more
- Communication Intervention
- +2 more
- New York, New York
- +1 more
2022-03-02
Mar 2, 2022M
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +129 more
- Cyclophosphamide
- +3 more
- Jacksonville, FloridaMayo Clinic in Florida
2022-02-25
Feb 25, 2022N
Active, not recruiting
- Clear Cell Renal Cell Carcinoma
- +6 more
- Orange, California
- +28 more
2022-03-01
Mar 1, 2022O
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +18 more
- Biopsy
- +25 more
- Portland, OregonOHSU Knight Cancer Institute
2022-02-11
Feb 11, 2022S
Withdrawn
- Advanced Malignant Neoplasm
- +10 more
- Brigatinib
- +3 more
- Columbus, OhioOhio State University Comprehensive Cancer Center
2022-02-15
Feb 15, 2022M
Active, not recruiting
- Locally Advanced Malignant Solid Neoplasm
- +2 more
- Pembrolizumab
- Pevonedistat
- Houston, TexasM D Anderson Cancer Center
2022-01-18
Jan 18, 2022M
Recruiting
- Locally Advanced Malignant Solid Neoplasm
- Metastatic Malignant Solid Neoplasm
- Larotrectinib Sulfate
- Houston, TexasM D Anderson Cancer Center
2021-12-21
Dec 21, 2021M
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +3 more
- Electroencephalography
- Questionnaire Administration
- Houston, TexasM D Anderson Cancer Center
2021-10-12
Oct 12, 2021M
Recruiting
- Advanced Malignant Solid Neoplasm
- +6 more
- Survey Administration
- Houston, TexasM D Anderson Cancer Center
2021-10-12
Oct 12, 2021U
Recruiting
- Locally Advanced Malignant Solid Neoplasm
- +3 more
- Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949
- VLP-encapsulated TLR9 Agonist CMP-001
- Scottsdale, Arizona
- +3 more
2021-10-14
Oct 14, 2021N
Withdrawn
- Aggressive Non-Hodgkin Lymphoma
- +3 more
- p97 Inhibitor CB-5339 Tosylate
- Bethesda, Maryland
- +1 more
2021-08-27
Aug 27, 2021U
Integrative Palliative Care/Psycho-Oncology Telehealth Intervention in Patients With Advanced Cancer
Recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Support Group Therapy
- +3 more
- San Francisco, CaliforniaUniversity of California, San Francisco
2021-08-20
Aug 20, 2021M
Not yet recruiting
- Locally Advanced Malignant Solid Neoplasm
- +3 more
- Houston, TexasM D Anderson Cancer Center
2021-08-10
Aug 10, 2021M
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +4 more
- Communication Intervention
- Questionnaire Administration
- Houston, TexasM D Anderson Cancer Center
2021-05-03
May 3, 2021R
Recruiting
- Clear Cell Renal Cell Carcinoma
- +10 more
- ATR Kinase Inhibitor AZD6738
- Olaparib
- San Francisco, CaliforniaUniversity of California, San Francisco
2021-04-05
Apr 5, 2021M
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +28 more
- Houston, TexasM D Anderson Cancer Center
2021-02-23
Feb 23, 2021M
Recruiting
- ALK Positive
- +5 more
- Ceritinib
- +3 more
- Houston, TexasM D Anderson Cancer Center
2020-02-14
Feb 14, 2020